These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 38253528)

  • 21. A dynamic application of PRECIS-2 to evaluate implementation in a pragmatic, cluster randomized clinical trial in two nursing home systems.
    Palmer JA; Mor V; Volandes AE; McCreedy E; Loomer L; Carter P; Dvorchak F; Mitchell SL
    Trials; 2018 Aug; 19(1):453. PubMed ID: 30134976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generalizability of randomized controlled trials in primary health care: Applying the PRECIS-2 tool on published protocols.
    Papagiannopoulou E; Laiou E; Tatsi C; Dimakopoulos G; Ntzani EE; Siamopoulos K; Tatsioni A
    J Eval Clin Pract; 2023 Mar; 29(2):253-262. PubMed ID: 36072984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of the characteristics and the degree of pragmatism exhibited by pragmatic-labelled trials of antineoplastic treatments.
    Saesen R; Depreytere K; Krupianskaya K; Langeweg J; Verheecke J; Lacombe D; Huys I
    BMC Med Res Methodol; 2023 Jun; 23(1):148. PubMed ID: 37355603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of Randomized Clinical Trials in Surgery From 2008 to 2020: A Systematic Review.
    Robinson NB; Fremes S; Hameed I; Rahouma M; Weidenmann V; Demetres M; Morsi M; Soletti G; Di Franco A; Zenati MA; Raja SG; Moher D; Bakaeen F; Chikwe J; Bhatt DL; Kurlansky P; Girardi LN; Gaudino M
    JAMA Netw Open; 2021 Jun; 4(6):e2114494. PubMed ID: 34190996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improving the relevance of randomised trials to primary care: a qualitative study investigating views towards pragmatic trials and the PRECIS-2 tool.
    Forbes G; Loudon K; Clinch M; Taylor SJC; Treweek S; Eldridge S
    Trials; 2019 Dec; 20(1):711. PubMed ID: 31829266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trends in the Explanatory or Pragmatic Nature of Cardiovascular Clinical Trials Over 2 Decades.
    Sepehrvand N; Alemayehu W; Das D; Gupta AK; Gouda P; Ghimire A; Du AX; Hatami S; Babadagli HE; Verma S; Kashour Z; Ezekowitz JA
    JAMA Cardiol; 2019 Nov; 4(11):1122-1128. PubMed ID: 31473763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How pragmatic or explanatory is the randomized, controlled trial? The application and enhancement of the PRECIS tool to the evaluation of a smoking cessation trial.
    Selby P; Brosky G; Oh PI; Raymond V; Ranger S
    BMC Med Res Methodol; 2012 Jul; 12():101. PubMed ID: 22824225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The need for more pragmatic trials in glaucoma research.
    Pacovska MF; de Amorim-Cabral CLD; Teixeira EGDRM; Kasahara N
    Eur J Ophthalmol; 2024 Apr; ():11206721241247428. PubMed ID: 38602016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Informing real-world practice with real-world evidence: the value of PRECIS-2.
    Neta G; Johnson KE
    BMC Med; 2018 May; 16(1):76. PubMed ID: 29783964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of meta-analytic methods for synthesizing evidence from explanatory and pragmatic trials.
    Sajobi TT; Li G; Awosoga O; Wang M; Menon BK; Hill MD; Thabane L
    Syst Rev; 2018 Jan; 7(1):19. PubMed ID: 29370830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Study characteristics impacted the pragmatism of randomized controlled trial published in nursing: a meta-epidemiological study.
    Devos F; Foissac F; Bouazza N; Ancel PY; Tréluyer JM; Chappuy H
    J Clin Epidemiol; 2019 Dec; 116():18-25. PubMed ID: 31374332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Framing the conversation: use of PRECIS-2 ratings to advance understanding of pragmatic trial design domains.
    Lipman PD; Loudon K; Dluzak L; Moloney R; Messner D; Stoney CM
    Trials; 2017 Nov; 18(1):532. PubMed ID: 29126437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pragmatic vs. explanatory: an adaptation of the PRECIS tool helps to judge the applicability of systematic reviews for daily practice.
    Koppenaal T; Linmans J; Knottnerus JA; Spigt M
    J Clin Epidemiol; 2011 Oct; 64(10):1095-101. PubMed ID: 21474282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pragmaticism of Randomized Controlled Trials of Biologic Treatment With Methotrexate in Rheumatoid Arthritis: A Systematic Review.
    Choi MY; Barnabe C; Barber CE; Bykerk V; Pope JE; Hazlewood GS
    Arthritis Care Res (Hoboken); 2019 May; 71(5):620-628. PubMed ID: 29908014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The value of the pragmatic-explanatory continuum indicator summary wheel in an ongoing study: the bullous pemphigoid steroids and tetracyclines study.
    Bratton DJ; Nunn AJ; Wojnarowska F; Kirtschig G; Sandell A; Williams HC
    Trials; 2012 Apr; 13():50. PubMed ID: 22540678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of pragmatism in explaining heterogeneity in meta-analyses of randomised trials: a protocol for a cross-sectional methodological review.
    Aves T; Allan KS; Lawson D; Nieuwlaat R; Beyene J; Mbuagbaw L
    BMJ Open; 2017 Sep; 7(9):e017887. PubMed ID: 28871028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers.
    Thorpe KE; Zwarenstein M; Oxman AD; Treweek S; Furberg CD; Altman DG; Tunis S; Bergel E; Harvey I; Magid DJ; Chalkidou K
    J Clin Epidemiol; 2009 May; 62(5):464-75. PubMed ID: 19348971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of explanatory and pragmatic design choices in a cluster-randomized hypertension trial: effects on enrollment, participant characteristics, and adherence.
    Margolis KL; Crain AL; Green BB; O'Connor PJ; Solberg LI; Beran M; Bergdall AR; Pawloski PA; Ziegenfuss JY; JaKa MM; Appana D; Sharma R; Kodet AJ; Trower NK; Rehrauer DJ; McKinney Z; Norton CK; Haugen P; Anderson JP; Crabtree BF; Norman SK; Sperl-Hillen JM
    Trials; 2022 Aug; 23(1):673. PubMed ID: 35978336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How can clinical practices pragmatically increase physical activity for patients with type 2 diabetes? A systematic review.
    Luoma KA; Leavitt IM; Marrs JC; Nederveld AL; Regensteiner JG; Dunn AL; Glasgow RE; Huebschmann AG
    Transl Behav Med; 2017 Dec; 7(4):751-772. PubMed ID: 28589531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Articles provided insufficient information to conduct an appropriate retrospective assessment of the pragmatic/explanatory features of medicine trials with the PRECIS-2 tool.
    Dal-Ré R
    Eur J Clin Pharmacol; 2020 Aug; 76(8):1093-1102. PubMed ID: 32447436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.